| Literature DB >> 33062180 |
Arun K Ghosh1,1, Alessandro Grillo1,1, Jakka Raghavaiah1, Satish Kovela1, Megan E Johnson1, Daniel W Kneller2, Yuan-Fang Wang2, Shin-Ichiro Hattori3, Nobuyo Higashi-Kuwata3, Irene T Weber2, Hiroaki Mitsuya3,4,5.
Abstract
The design, synthesis, biological evaluation, and X-ray structural studies are reported for a series of highly potent HIV-1 protease inhibitors. The inhibitors incorporated stereochemically defined amide-based bicyclic and tricyclic ether derivatives as the P2 ligands with (R)-hydroxyethylaminesulfonamide transition-state isosteres. A number of inhibitors showed excellent HIV-1 protease inhibitory and antiviral activity; however, ligand combination is critical for potency. Inhibitor 4h with a difluorophenylmethyl as the P1 ligand, crown-THF-derived acetamide as the P2 ligand, and a cyclopropylaminobenzothiazole P2'-ligand displayed very potent antiviral activity and maintained excellent antiviral activity against selected multidrug-resistant HIV-1 variants. A high resolution X-ray structure of inhibitor 4h-bound HIV-1 protease provided molecular insight into the binding properties of the new inhibitor.Entities:
Year: 2020 PMID: 33062180 PMCID: PMC7549267 DOI: 10.1021/acsmedchemlett.9b00670
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345